NCT00513643View on ClinicalTrials.gov

Metabolic Effect of Insulin Aspart and Human Insulin in Different Doses

PHASE1CompletedINTERVENTIONAL

Enrollment

16

Participants

Timeline

Start Date

April 30, 2002

Study Completion Date

June 30, 2002

Conditions

Diabetes Mellitus

Interventions

DRUG

insulin aspart

6, 12, 24 U s.c.

DRUG

human regular insulin

6, 12 and 24 IU sc

Trial Locations (1)

41460

Profil Institut für Stoffwechselforschung GmbH, Neuss

Sponsors

Collaborators (1)

Novo Nordisk A/S

All Listed Sponsors

collaborator

Novo Nordisk A/S

INDUSTRY

lead

Profil Institut für Stoffwechselforschung GmbH

INDUSTRY

NCT00513643 - Metabolic Effect of Insulin Aspart and Human Insulin in Different Doses | Biotech Hunter | Biotech Hunter